A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
Part of paid clinical trials in Walnut Creek, California.
- Sponsor
- Boehringer Ingelheim
- Study ID
- NCT04667377
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- BI 456906 — DRUGBI 456906
- Placebo — DRUGPlacebo
Study Details
This study is open to adults, aged 18 to 75 years, with overweight or obesity. People with body mass index (BMI) of 27 or higher to join the study. People who have diabetes cannot participate. The purpose of this study is to find out whether a medicine called BI 456906 helps people lose weight. Participants are put into 5 groups by chance. 4 groups get different doses of BI 456906. The fifth group gets placebo. Participants get BI 456906 or placebo as injections under the skin once a week. Placebo injections look like BI 456906 injections but do not contain any medicine. Participants are in the study for about a year. During this time, there are about 20 in-person visits to the study site. At the study site visits, doctors measure participants' body weight. Results are compared between the BI 456906 groups and the placebo group. The doctors also regularly check the general health of the participants.
Key Dates
- Start date
- Mar 8, 2021
- Status verified
- Oct 2023
- Primary completion
- Sep 15, 2022
- Completion
- Oct 7, 2022
Study Design
- Enrollment
- 387 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 0.6 mg BI 456906
- Placebo Comparator: Placebo group
- Experimental: 2.4 mg BI456906
- Experimental: 3.6 mg BI 456906
- Experimental: 4.8 mg BI 456906
Primary Outcome Measure
Percentage Change in Body Weight From Baseline to Week 46 [ Time Frame: Baseline, Week 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 24, 28, 32, 36, 40, and 46. ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Diablo Clinical Research | Walnut Creek | California | 94598 | - |
| L-MARC Research Center | Louisville | Kentucky | 40213 | - |
| Lucas Research, Inc. | Morehead City | North Carolina | 28557 | - |
| PMG Research of Wilmington, LLC | Wilmington | North Carolina | 28401 | - |
| Valley Weight Loss Clinic | Fargo | North Dakota | 58104 | - |
| Velocity Clinical Research, Inc. | Cleveland | Ohio | 44122 | - |
| TLM Medical Services, LLC | Columbia | South Carolina | 29204 | - |
| Coastal Carolina Research Center | North Charleston | South Carolina | 29405 | - |
| Washington Center for Weight Management and Research, Inc. | Arlington | Virginia | 22206 | - |
| Allegiance Research Specialists | Wauwatosa | Wisconsin | 53226 | - |
Find similar trials in Walnut Creek, CA
Related Studies
- Investigating the Impact of Obesity on Pubertal Development in GirlsRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina
- Inflammation, Diabetes, Ethnicity and Obesity CohortRecruiting · University of California, San Francisco · San Francisco, California
- Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesPHASE2 · Recruiting · University of Colorado, Denver · Durham, North Carolina
- Adrenergic Cholinergic Enteric Measures/MappingRecruiting · University of Louisville · Louisville, Kentucky